- Home
- GAB vs CLDX Comparison
GAB vs CLDX Comparison
Compare GAB & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAB
- CLDX
- Stock Information
- Founded
- GAB 1986
- CLDX N/A
- Country
- GAB United States
- CLDX United States
- Employees
- GAB N/A
- CLDX N/A
- Industry
- GAB Investment Managers
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GAB Finance
- CLDX Health Care
- Exchange
- GAB Nasdaq
- CLDX Nasdaq
- Market Cap
- GAB 1.9B
- CLDX 1.6B
- IPO Year
- GAB N/A
- CLDX 2008
- Fundamental
- Price
- GAB $5.93
- CLDX $26.77
- Analyst Decision
- GAB
- CLDX Buy
- Analyst Count
- GAB 0
- CLDX 9
- Target Price
- GAB N/A
- CLDX $43.78
- AVG Volume (30 Days)
- GAB 667.8K
- CLDX 942.5K
- Earning Date
- GAB 01-01-0001
- CLDX 11-05-2025
- Dividend Yield
- GAB 10.91%
- CLDX N/A
- EPS Growth
- GAB N/A
- CLDX N/A
- EPS
- GAB N/A
- CLDX N/A
- Revenue
- GAB N/A
- CLDX $5,790,000.00
- Revenue This Year
- GAB N/A
- CLDX N/A
- Revenue Next Year
- GAB N/A
- CLDX N/A
- P/E Ratio
- GAB N/A
- CLDX N/A
- Revenue Growth
- GAB N/A
- CLDX N/A
- 52 Week Low
- GAB $4.56
- CLDX $14.40
- 52 Week High
- GAB $5.88
- CLDX $29.93
- Technical
- Relative Strength Index (RSI)
- GAB 39.19
- CLDX 56.87
- Support Level
- GAB $5.87
- CLDX $26.10
- Resistance Level
- GAB $6.05
- CLDX $27.87
- Average True Range (ATR)
- GAB 0.08
- CLDX 1.18
- MACD
- GAB -0.02
- CLDX -0.07
- Stochastic Oscillator
- GAB 19.05
- CLDX 67.91
About GAB Gabelli Equity Trust Inc. (The)
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.